medigraphic.com
SPANISH

CorSalud (Revista de Enfermedades Cardiovasculares)

ISSN 2078-7170 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2021, Number 3

<< Back Next >>

CorSalud 2021; 13 (3)

Very late thrombosis of a bare metal stent: An unexpected event

González VA, Barreda PAM, López FLH, Llerena RLD, Alfonso RE, Ramos BS
Full text How to cite this article

Language: Spanish
References: 16
Page: 367-371
PDF size: 296.64 Kb.


Key words:

stent thrombosis, acute myocardial infarction, percutaneous coronary intervention.

ABSTRACT

Very late stent thrombosis is a rare complication but with high morbidity and mortality. Predisposing factors include clinical, anatomical and procedure-related parameters. Many pathophysiological mechanisms are considered to be responsible for stent thrombosis. The treatment of this complication consists of attempting to restore blood flow as soon as possible. We present the case of an individual diagnosed with ST-segment elevation myocardial infarction after very late thrombosis of conventional bare metal stent (20 months). The patient was successfully treated by percutaneous coronary intervention with two sirolimus-eluting stents.


REFERENCES

  1. Torrado J, Buckley L, Durán A, Trujillo P, Toldo S, Valle Raleigh J, et al. Restenosis, Stent Thrombosis, and Bleeding Complications: Navigating Between Scylla and Charybdis. J Am Coll Cardiol. 2018;71(15):1676-95. DOI: https://doi.org/10.1016/j.jacc.2018.02.023

  2. Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R, et al. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation. 2009;119(25):3198-206. DOI: https://doi.org/10.1161/circulationaha.108.826479

  3. Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Eur J Cardiothorac Surg. 2018;53(1):34-78. DOI: https://doi.org/10.1093/ejcts/ezx334

  4. Raghavendra Rao K, Reddy S, Kashyap JR, Vikas K, Reddy H, Ramalingam V, et al. Acute Coronary Syndrome after 17 Years of Bare Metal Stent Implantation: "Very" Very Late Stent Thrombosis. Case Rep Cardiol [Internet]. 2020 [cited 25 Jun 2020];2020:9628719. Disponible en: https://doi.org/10.1155/2020/9628719

  5. Soto G, Sepúlveda P, Donoso H, Puentes A, Bellet A, Albisú G, et al. Trombosis "extremadamente" tardía de stent. Rev Chil Cardiol. 2012;31(3):263-6. DOI: http://dx.doi.org/10.4067/S0718-85602012000300011

  6. García Hernández RA, Rivero Seriel L, Romero Millares RL. Trombosis muy tardía de stent convencional. A propósito de un caso. CorSalud [Internet]. 2018 [citado 27 Jun 2020];10(1):89-93. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/297/647

  7. Garcia-Garcia HM, McFadden EP, Farb A, Mehran R, Stone GW, Spertus J, et al. Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document. Circulation. 2018;137(24):2635-50. DOI: https://doi.org/10.1161/circulationaha.117.029289

  8. Mori H, Finn AV. Avances reveladores sobre la trombosis. Rev Esp Cardiol. 2017;70(12):1036-8. DOI: https://doi.org/10.1016/j.recesp.2017.06.015

  9. Adriaenssens T, Joner M, Godschalk TC, Malik N, Alfonso F, Xhepa E, et al. Optical Coherence Tomography Findings in Patients With Coronary Stent Thrombosis: A Report of the PRESTIGE Consortium (Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort). Circulation. 2017;136(11):1007-21. DOI: https://doi.org/10.1161/circulationaha.117.026788

  10. Souteyrand G, Amabile N, Mangin L, Chabin X, Meneveau N, Cayla G, et al. Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry. Eur Heart J. 2016;37(15):1208-16. DOI: https://doi.org/10.1093/eurheartj/ehv711

  11. Taniwaki M, Radu MD, Zaugg S, Amabile N, Garcia-Garcia HM, Yamaji K, et al. Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence Tomography. Circulation. 2016;133(7):650-60. DOI: https://doi.org/10.1161/circulationaha.115.019071

  12. Filgueiras Frías CE, Bestard Bicet R, Laria Menchaca S, López Ferrero L, Pérez del Todo JM, Villanueva Ponte LH. Trombosis muy tardía de stent convencional. Una sorpresa desagradable. Rev Cuban Cardiol [Internet]. 2011 [citado 3 Jul 2020];17(2):180-5. Disponible en: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/64/42

  13. Wang X, Chen X, Tian T, You H, Li Y, Wu M, et al. A scoring system to predict the occurrence of very late stent thrombosis following percutaneous coronary intervention for acute coronary syndrome. Sci Rep [Internet]. 2020 [cited 3 Jul 2020];10(1):6378. Disponible en: https://doi.org/10.1038/s41598-020-63455-0

  14. Fuentes L, Gómez-Lara J, Salvatella N, Gonzalo N, Hernández-Hernández F, Fernández-Nofrerias E, et al. Hallazgos por IVUS en trombosis de stent tardía y muy tardía. Comparación entre stents metálicos y farmacoactivos. Rev Esp Cardiol. 2017;71(5):335-43. DOI: https://doi.org/10.1016/j.recesp.2017.07.024

  15. Alfonso F, Rivero F. Optical coherence tomography to optimize stent deployment: seeing is believing. Rev Esp Cardiol. 2015;68(3):175-8. DOI: https://doi.org/10.1016/j.rec.2014.09.017

  16. de la Torre Hernández JM, Windecker S. Trombosis muy tardía con nuevos stents farmacoactivos, ¿ha dejado de ser un asunto relevante?. Rev Esp Cardiol. 2012;65(7):595-8. DOI: https://doi.org/10.1016/j.recesp.2012.01.017




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

CorSalud. 2021;13